NCT05035121

Brief Summary

The purpose of this study was determine whether milk or soy milk supplements combined with resistance exercise improved sarcopenia in the elderly. This study was randomized controlled trail that recruited elderly people ≧65 years old with sarcopenia in the nursing home of Taipei Veterans General Hospital Su-Ao and Yuanshan Branch from June 2017 to December, 2017. The participants were divided into three groups, such as control, milk supplement and soy milk supplement. The milk and soy milk groups provided 200 mL milk or soy milk two times per day. Moreover, all participants joined the resistance exercise training program, three times per week (30 min/time). After 12 weeks, the anthropometry, sarcopenia index, blood biochemical index, nutrition status index, inflammation index, insulin resistance index, and dietary intake were measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 24, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2018

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 5, 2021

Completed
Last Updated

September 5, 2021

Status Verified

August 1, 2021

Enrollment Period

10 months

First QC Date

May 24, 2021

Last Update Submit

August 31, 2021

Conditions

Keywords

sarcopeniamilksoy milkresistance exercise

Outcome Measures

Primary Outcomes (18)

  • appendicular skeletal muscle mass in kilograms

    The appendicular skeletal muscle mass was evaluated by bioelectrical impedance (BIA) analysis (Inbody S10, Inbody Inc., Seoul, South Korea)

    baseline

  • Change from baseline appendicular skeletal muscle mass at 6 weeks

    The appendicular skeletal muscle mass was evaluated by bioelectrical impedance (BIA) analysis (Inbody S10, Inbody Inc., Seoul, South Korea)

    6 weeks

  • Change from baseline appendicular skeletal muscle mass at 12 weeks

    The appendicular skeletal muscle mass was evaluated by bioelectrical impedance (BIA) analysis (Inbody S10, Inbody Inc., Seoul, South Korea)

    12 weeks

  • height in meters

    Height was measured by height meter

    baseline

  • Change baseline weeks height at 6 weeks

    Height was measured by height meter

    6 weeks

  • Change from baseline height at 12 weeks

    Height was measured by height meter

    12 weeks

  • appendicular skeletal muscle mass index in kg/m^2

    The appendicular skeletal muscle mass muscle mass and height was combined to report appendicular skeletal muscle mass index in kg/m\^2.

    baseline

  • Change from baseline appendicular skeletal muscle mass index at 6 weeks

    The appendicular skeletal muscle mass muscle mass and height was combined to report appendicular skeletal muscle mass index in kg/m\^2.

    6 weeks

  • Change from baseline appendicular skeletal muscle mass index at 12 weeks

    The appendicular skeletal muscle mass muscle mass and height was combined to report appendicular skeletal muscle mass index in kg/m\^2.

    12 weeks

  • calf circumferences in centimeter

    calf circumferences (cm) was measured by using a measuring tape to go around the thickest point of the calf and stick tightly without squeezing the skin.

    baseline

  • Change from baseline calf circumferences at 6 weeks

    calf circumferences (cm) was measured by using a measuring tape to go around the thickest point of the calf and stick tightly without squeezing the skin.

    6 weeks

  • Change from baseline calf circumferences at 12 weeks

    calf circumferences (cm) was measured by using a measuring tape to go around the thickest point of the calf and stick tightly without squeezing the skin.

    12 weeks

  • hand grip in kilograms

    The muscle strength was evaluated with the hand-grip strength (kg) using a Smedley dynamometer (TTM-YD, Tsutsumi Industries, Tokyo, Japan)

    baseline

  • Change from baseline hand grip at 6 weeks

    The muscle strength was evaluated with the hand-grip strength (kg) using a Smedley dynamometer (TTM-YD, Tsutsumi Industries, Tokyo, Japan)

    6 weeks

  • Change from baseline hand grip at 12 weeks

    The muscle strength was evaluated with the hand-grip strength (kg) using a Smedley dynamometer (TTM-YD, Tsutsumi Industries, Tokyo, Japan)

    12 weeks

  • gait speed in meter per second

    The gait speed test was performed by recording the average time of walking 6 meters and representing with the distance (m) per second.

    baseline

  • Change from baseline gait speed at 6 weeks

    The gait speed test was performed by recording the average time of walking 6 meters and representing with the distance (m) per second.

    6 weeks

  • Change from baseline gait speed at 12 weeks

    The gait speed test was performed by recording the average time of walking 6 meters and representing with the distance (m) per second.

    12 weeks

Secondary Outcomes (20)

  • blood alanine transaminase activity in U/L

    baseline

  • Change from baseline blood alanine transaminase activity at 12 weeks

    12 weeks

  • blood creatinine level in mg/dL

    baseline

  • Change from baseline blood creatinine level at 12 weeks

    12 weeks

  • blood prealbumin level in mg/dL

    baseline

  • +15 more secondary outcomes

Other Outcomes (2)

  • diet assessment

    baseline

  • Change from baseline diet assessment at 12 weeks

    12 weeks

Study Arms (3)

milk supplement

EXPERIMENTAL

The milk group provided 200 mL milk two times per day. The participants joined the resistance exercise training program, three times per week (30 min/time) during 12 weeks.

Dietary Supplement: milk supplementBehavioral: resistance exercise

soy milk supplement

EXPERIMENTAL

The soy milk group provided 200 mL soy milk two times per day. The participants joined the resistance exercise training program, three times per week (30 min/time) during 12 weeks.

Dietary Supplement: soy milk supplementBehavioral: resistance exercise

control

PLACEBO COMPARATOR

The participants joined the resistance exercise training program, three times per week (30 min/time) during 12 weeks.

Behavioral: resistance exercise

Interventions

milk supplementDIETARY_SUPPLEMENT

Intervention groups provided 200 mL long life milk two times per day at morning and afternoon. The participants joined the resistance exercise training program, three times per week (30 min/time)

milk supplement
soy milk supplementDIETARY_SUPPLEMENT

Intervention groups provided 200 mL long life soy milk two times per day at morning and afternoon. The participants joined the resistance exercise training program, three times per week (30 min/time)

soy milk supplement

The participants joined the resistance exercise training program, three times per week (30 min/time)

controlmilk supplementsoy milk supplement

Eligibility Criteria

Age65 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≧ 65 years old
  • No allergies to milk and soy milk
  • Sarcopenia cases (AWGS)
  • Active ability

You may not qualify if:

  • End-of-life patient or estimated death within six months
  • Last stage of cancer
  • Chronic kidney disease stage 4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University

New Taipei City, Taiwan

Location

MeSH Terms

Conditions

Sarcopenia

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The participants were divided into three groups, such as control, milk supplement and soy milk supplement. The milk and soy milk groups provided 200 mL milk or soy milk two times per day. Moreover, all participants joined the resistance exercise training program, three times per week (30min/time).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 24, 2021

First Posted

September 5, 2021

Study Start

March 24, 2017

Primary Completion

January 23, 2018

Study Completion

March 23, 2018

Last Updated

September 5, 2021

Record last verified: 2021-08

Locations